Company · CIK 0001401040 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
DiaMedica Therapeutics Inc. · DMAC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 AForm 4 → | Aug 12, 4:23 pm EDT | Dietrich John PaulsPresident & CEO, Director | 60,200 | — | — | 128,791 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.